A trial to study of treatment with a new PPI for infection of H. pylori with Clarithromycin resistance

Trial Profile

A trial to study of treatment with a new PPI for infection of H. pylori with Clarithromycin resistance

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 11 Feb 2017

At a glance

  • Drugs Vonoprazan (Primary) ; Amoxicillin; Metronidazole; Rabeprazole
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 12 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top